MétaCan
Menu
Back to cohort
Record W3029272205 · doi:10.1016/j.annonc.2020.05.019

Prognostic gene expression signature for high-grade serous ovarian cancer

2020· review· en· W3029272205 on OpenAlexafffund
Joshua Millstein, Timothy Budden, Ellen L. Goode, Michael S. Anglesio, Aline Talhouk, Maria P. Intermaggio, Huei San Leong, Shuang Chen, Wafaa Elatre, C. Blake Gilks, Tayyebeh M. Nazeran, Mila Volchek, Rex C. Bentley, C. Wang, Derek S. Chiu, Stefan Kommoss, Samuel Leung, Janine Senz, Amy Lum, Vickie Chow, Hanwei Sudderuddin, Robertson Mackenzie, Joshy George, David D.L. Bowtell, Georgia Chenevix‐Trench, A. Green, Penelope M. Webb, Anna DeFazio, Dorota M. Gertig, Nadia Traficante, Sián Fereday, Sue Moore, Jillian A. Hung, K.R. Harrap, T. Sadkowsky, Nirmala Pandeya, M. Malt, Anne Mellon, R. Paul Robertson, T. Vanden Bergh, Marsha Jones, P. Mackenzie, J. Maidens, K. Nattress, Yoke-Eng Chiew, Annie Stenlake, Harold C. Sullivan, B. Alexander, P. Ashover, Scott D. Brown, T. Corrish, L. Green, L. M. Jackman, Kaltin Ferguson, Karla Martin, A. Martyn, B. Ranieri, Jeff White, V. Jayde, Pamela Mamers, Leanne Bowes, Laura Galletta, Daniel A. Giles, Joy Hendley, Kathryn Alsop, Tannin A. Schmidt, H. Shirley, Colleen T. Ball, Christian D. Young, S. Viduka, Hoa Tran, Sanela Bilic, Lydia Glavinas, Julia Brooks, R. Stuart‐Harris, Fred Kirsten, J Rutovitz, P. Clingan, Akisha Glasgow, Anthony Proietto, Stephen Braye, Geoffrey Otton, Jenny Shannon, Tony Bonaventura, Jocelyn M. Stewart, Stephen Begbie, Michael Friedländer, Dany Bell, Sally Baron‐Hay, A. Ferrier, G. Gard, David Nevell, Nick Pavlakis, Susan Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, Neville F. Hacker, Donald E. Marsden, Greg Robertson, Philip Beale, Jane Beith, J. Carter, C. Dalrymple, R. Houghton, Peter Russell, Matthew Links, John J. Grygiel, Jane Hill, Alison H. Brand, Karen Byth, Richard Jaworski, Paul R. Harnett, Raghwa Sharma, Gerard Wain, B Ward, D. Papadimos, A. Crandon, Michael P. Cummings, K. Horwood, Andreas Obermair, Lewis Perrin, David Wyld, James Nicklin, Martin Davy, Martin K. Oehler, Christopher L. Hall, Tom Dodd, Timothy M. Healy, Keir Pittman, Doug Henderson, J. Miller, J. Pierdes, Penny Blomfield, D. Challis, Rachel McIntosh, Alyssa Parker, Robert Brown, Robert Rome, Deborah Allen, Peter Grant, Simon Hyde, R. Laurie, Melissa Robbie, David Healy, Thomas W. Jobling, T. Manolitsas, J. McNealage, Peter A. W. Rogers, B. Susil, E. Sumithran, Ian Simpson, Kelly‐Anne Phillips, Danny Rischin, Stephen B. Fox, Daryl Johnson, Stephen Lade, Maurice B. Loughrey, N. O’Callaghan, William K. Murray, Paul Waring, Virginia Billson, Jan Pyman, Deborah Neesham, Michael Quinn, Craig Underhill, Rachel Bell, L. F. Ng, Robert Blum, Vinod Ganju, Ian Hammond, Yee Leung, Anthony J. McCartney, Marion G. Buck, I. Haviv, D. Purdie, David C. Whiteman, Nikolajs Zeps, Helen Steed, Jennifer M. Koziak, Martin Köbel, Iain A. McNeish, Teodora Goranova, D. Ennis, Geoff Macintyre, D. Silva De Silva, Teresa Ramón y Cajal, Jesús García-Donás, Susanna Hernando Polo, Gus Rodriguez, Kara L. Cushing‐Haugen, Holly R. Harris, Casey S. Greene, René A. Zelaya, Sabine Behrens, Renée T. Fortner, Hans‐Peter Sinn, Esther Herpel, Jenny Lester, Jan Lubiński, Oleg Oszurek, Aleksandra Tołoczko, Cezary Cybulski, Janusz Menkiszak, Celeste Leigh Pearce, Malcolm C. Pike, Chiu-Chen Tseng, Jennifer Alsop, Valerie Rhenius, Honglin Song, Mercedes Jimenez‐Liñan, Anna Piskorz, A. Gentry-Maharaj, Chloe Karpinskyj, Martin Widschwendter, Naveena Singh, Catherine J. Kennedy, Bo Gao, Sharon E. Johnatty, R. Drew Sayer, Jessica Boros, Stacey J. Winham, Gary L. Keeney, Scott H. Kaufmann, Melissa C. Larson, Hui‐Ying Luk, Brenda Y. Hernandez, Pamela J. Thompson, Lynne R. Wilkens, Michael E. Carney, Britton Trabert, Jolanta Lissowska, Louise A. Brinton, Mark E. Sherman, Clara Bodelón, Samantha Hinsley, Liz-Anne Lewsley, Rosalind Glasspool, Susana Banerjee, Euan A. Stronach, Paul Haluska, Isabelle Ray‐Coquard, Sven� Mahner, Boris Winterhoff, Dennis J. Slamon, Douglas A. Levine, Linda E. Kelemen, Javier Benı́tez, Jenny Chang‐Claude, J. Gronwald, Anna H. Wu, Usha Menon, Marc T. Goodman, Joellen M. Schildkraut, Nicholas Wentzensen, Andrew Berchuck, Simon A. Gayther, María J. García, Michelle J. Henderson, Mary Anne Rossing, Alicia Beeghly‐Fadiel, Peter A. Fasching, Sandra Oršulić, Beth Y. Karlan, Gottfried E. Konecny, David G. Huntsman, James D. Brenton, J.A. Doherty, Paul D.P. Pharoah, Susan J. Ramus

Bibliographic record

VenueAnnals of Oncology · 2020
Typereview
Languageen
FieldMedicine
TopicOvarian cancer diagnosis and treatment
Canadian institutionsUniversity of CalgaryVancouver General HospitalAlberta Health ServicesUniversity of British ColumbiaRoyal Alexandra HospitalFoothills Medical CentreBC Cancer Agency
FundersMedical Research and Materiel CommandNational Cancer InstituteCancer Council TasmaniaCancer Council NSWCancer Council VictoriaCancer Council South AustraliaNational Center for Advancing Translational SciencesMedical Research CouncilOak FoundationBC Cancer FoundationU.S. Department of DefenseEli Lilly and CompanyIgnytaDr. Miriam and Sheldon G. Adelson Medical Research FoundationNational Institutes of HealthCanada Research ChairsCanadian Institutes of Health ResearchCancer Institute NSWCancer Research UKUniversity College LondonCancer AustraliaOvarian Cancer ActionClovis OncologyNational Institute for Health and Care ResearchHorizon 2020 Framework ProgrammeNational Health and Medical Research CouncilInvitaeAstraZenecaCarrick TherapeuticsPfizerUniversity College London Hospitals NHS Foundation TrustEuropean Commission
KeywordsMedicineSerous ovarian cancerOvarian cancerSerous fluidGene signatureOncologySignature (topology)Internal medicineGeneCancerCancer researchGene expressionGenetics

Abstract

fetched live from OpenAlex

BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated with prognosis. The aim of this study was to develop a robust prognostic signature for OS in patients with HGSOC. PATIENTS AND METHODS: Expression of 513 genes, selected from a meta-analysis of 1455 tumours and other candidates, was measured using NanoString technology from formalin-fixed paraffin-embedded tumour tissue collected from 3769 women with HGSOC from multiple studies. Elastic net regularization for survival analysis was applied to develop a prognostic model for 5-year OS, trained on 2702 tumours from 15 studies and evaluated on an independent set of 1067 tumours from six studies. RESULTS: Expression levels of 276 genes were associated with OS (false discovery rate < 0.05) in covariate-adjusted single-gene analyses. The top five genes were TAP1, ZFHX4, CXCL9, FBN1 and PTGER3 (P < 0.001). The best performing prognostic signature included 101 genes enriched in pathways with treatment implications. Each gain of one standard deviation in the gene expression score conferred a greater than twofold increase in risk of death [hazard ratio (HR) 2.35, 95% confidence interval (CI) 2.02-2.71; P < 0.001]. Median survival [HR (95% CI)] by gene expression score quintile was 9.5 (8.3 to -), 5.4 (4.6-7.0), 3.8 (3.3-4.6), 3.2 (2.9-3.7) and 2.3 (2.1-2.6) years. CONCLUSION: The OTTA-SPOT (Ovarian Tumor Tissue Analysis consortium - Stratified Prognosis of Ovarian Tumours) gene expression signature may improve risk stratification in clinical trials by identifying patients who are least likely to achieve 5-year survival. The identified novel genes associated with the outcome may also yield opportunities for the development of targeted therapeutic approaches.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.936
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.154
GPT teacher head0.445
Teacher spread0.291 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations173
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of OncologySame topicOvarian cancer diagnosis and treatmentFrench-language works237,207